(Q57756620)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212778%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

title

Impact of intra-individual molecular heterogeneity in personalized treatment of hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212778%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

main subject

hepatocellular carcinoma

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212778%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Josep M. Llovet

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212778%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

author name string

Augusto Villanueva

series ordinal

1

0 references

language of work or name

English

0 references

publication date

1 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212778%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212778%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212778%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212778%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

page(s)

2416-2419

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212778%20AND%20SRC:MED&resulttype=core&format=json

FDA drug approval summary: gefitinib (ZD1839) (Iressa) tablets

19 February 2020

cites work

1 reference

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

21 January 2018

1 reference

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

21 January 2018

1 reference

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

21 January 2018

1 reference

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

21 January 2018

1 reference

Cancer. Addiction to oncogenes--the Achilles heal of cancer

21 January 2018

1 reference

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma.

21 January 2018

1 reference

Targeted therapies for hepatocellular carcinoma.

21 January 2018

1 reference

The clonal evolution of tumor cell populations

21 January 2018

1 reference

How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine

21 January 2018

1 reference

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

21 January 2018

1 reference

The patterns and dynamics of genomic instability in metastatic pancreatic cancer

21 January 2018

1 reference

Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies

21 January 2018

1 reference

Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data

21 January 2018

1 reference

Cell population genetics and deep sequencing: A novel approach for drivers discovery in hepatocellular carcinoma

21 January 2018

1 reference

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

21 January 2018

1 reference

Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma

21 January 2018

1 reference

Decoding global gene expression programs in liver cancer by noninvasive imaging

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/HEP.26124

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23212778%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference